2024 annual financial data
Kymera Therapeutics 2024 Operating margin
Direct answer
Operating margin was -555.82%.
Operating income was -261,635,000 USD and net income was -223,858,000 USD.
Operating cash flow was -194,501,000 USD.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47,072,000 USD
- Operating income
- -261,635,000 USD
- Net income
- -223,858,000 USD
- Operating cash flow
- -194,501,000 USD